Summit Therapeutics Share Discussion Threads

[waterloo01] 17/10/2016 14:29

Chrisatdrg, so you're no share guru. Neither am I.

[chrisatrdg] 17/10/2016 11:07

Hi waterloo01 Based on share price drop today my recent investment clearly bad timing.Oh dear!

[waterloo01] 14/10/2016 18:44

Hyper I don't think the money is hypothicated, so can spend as they please. The unknown is the RDZ deal, hopefully it will add funds rather than be a cost re the phase 3. However the current cash will be used (including the future milestones)to pay our 55% to get EZD through the placebo phase 2 (which in many ways is actually a phase 3) and - if it works - the reward, approval. IF approved then we can test Freedosh's valuations!

Chrisatdrg, goodness, willing to get another earful from the 'sisters'. Is that wise? (I also bought a token 1000 today at 1.83)

[joe shone] 14/10/2016 16:11

without RG we would be over £3.00 now.wish he would p-ss off

[luminoso] 14/10/2016 15:58

RG still got a few to dump over here, it seems. US going for it now.

[freemoney1] 14/10/2016 14:06

Looks like the bounce is taking hold and moving up on low volume. Shares must be in short supply. Long way to go for fair value yet, as many have said, judging by our market cap compared to Sarepta, and our whole market DMD potential. Roll on EZD proof of concept which should leave this lowly share price a distant memory. I expect the RDZ announcement to be transformational before then as well. GLA

[someuwin] 14/10/2016 13:59

This should soon get back to the high it hit on the day of the announcement....and beyond.

[chrisatrdg] 14/10/2016 13:25

Solomon I had tried for support earlier & as a token bought myself 250 shares for 92p rather than the 25,000 I wanted to Buy so we are trying to catch up - the rest of the money is in the bank earning virtually nothing (Hope the share price does not drop).

Edit: I seem to be the last one to show as a Buy.

Edit: Not now & maybe this could be the breakout that happened in Sept. 2013 when share price went to 19p old money not that it will go that high without C-Diff deal.

[solomon] 14/10/2016 13:15

chrisatrdg, your wife backs you? I am interested in how you get the lady interested, if I am not being too personal.
There was a forum thread started yesterday by Martin Lewis on his MSE website regarding the lack of shared interest in money matters between spouses:

[chrisatrdg] 14/10/2016 13:06

Just bought back in backed by wife 2,600 at 193.80 hope it was right move.I agree with others on this board that it looks like the bottom has been reached pity I did not Buy yesterday.

[solomon] 14/10/2016 13:05

If there were open shorts on Nasdaq and the holders did not have guaranteed stops then the possible gap up on SMMT at open will trigger closing at the up-gapped price.

[hugus maximus] 14/10/2016 13:00

What an extraordinary share price turnaround today ... is this really all down to the Fibbo .. data calculating market trends is now influencing it?

[someuwin] 14/10/2016 12:03

The only thing that had been holding me back previously was their lack of cash. Now they're fully funded for the next two years I'm happy to keep adding at what seem to be a massive discount to their peers (specifically Sarepta).

"...The Company believes that its existing cash and cash equivalents, and the receipt of a $40.0 million upfront payment in connection with its entry into the Collaboration Agreement and an anticipated $22.0 million payment for a near-term regulatory milestone under the Collaboration Agreement, will be sufficient to enable the Company to fund its operating expenses and capital expenditure requirements through 31 December 2018."

[freedosh] 14/10/2016 11:07

Utrophin modulation is oral, potentially universal (DMD and Becker's)and if we get good efficacy will make SUMM worth many times that of SRPT, IMO.
Long term we need to look at genetic correction. The ex-vivo technology is there but in-vivo will be very difficult.

[someuwin] 14/10/2016 10:46

Sarepta valuation $2.8bn.

Summit valuation £110m.

With both companies so closely linked now, why is there such a disparity in valuations? Surely Summit's potential is greater than Sarepta's?

[freedosh] 14/10/2016 10:45

Lowlife, Solomon. I have no time for shorters. There was only about 3% on loan in US. Suggests naked shorting there

[solomon] 14/10/2016 10:34

Who would short a company that is trying to alleviate the suffering of young children with DMD and old folks with recurring C. Diff? I mean who would do that?

[freedosh] 14/10/2016 10:07

Code 2
Was code 1 to short? Appeared twice
If code 2 is to close shorts we might have cracked it
ConspiracytheoriesRUs

[abergele] 14/10/2016 08:42

I hope so Hy.AL,...
It sickened me,as with you watching the profits dwindle away in front of our eyes while many flogged/sold it away,..It's a free world and many I suppose were only chasing the kill as you may say...then exit quickly with a profit....

gla..lth's...

[waterloo01] 14/10/2016 08:41

When has this ever leaked?

[football] 14/10/2016 08:40

your not sure if it's over sold(i think so)or there is a leak again and buying before the 12pm Rns

[chrisatrdg] 14/10/2016 08:36

Per Barclays Stockbrokers mins ago plus 7.5 hopefully the start of the recovery.

[someuwin] 14/10/2016 08:34

Looks like the right time to be buying